Vaccine News and Research

Latest Vaccine News and Research

Canadians would welcome HPV vaccine if it were free

Canadians would welcome a vaccine against the human papillomavirus (HPV) if it were introduced at no charge, a Quebec, Canada survey suggests.

24 Oct 2007

Novel strategy to inactivate Venezuelan equine encephalitis virus

A collaborative team of scientists from the Uniformed Services University of the Health Sciences (USU) and the National Cancer Institute (NCI) have developed a novel strategy to inactivate highly virulent Venezuelan equine encephalitis virus (VEEV) that can infect and kill both animals and humans.

24 Oct 2007

Influenza vaccine production capacity on the rise

Recent scientific advances and increased vaccine manufacturing capacity have prompted experts to increase their projections of how many pandemic influenza vaccine courses can be made available in the coming years.

24 Oct 2007

In the event of a bird flu pandemic more vaccine will be ready

The World Health Organization (WHO) has revised it's estimate of how much bird flu vaccine could be available were a pandemic scenario to unfold.

24 Oct 2007

New flu pandemic plans for U.S.

In the event of a flu pandemic in the United States new government plans detail who will be the first to get vaccinated.

24 Oct 2007

Link between obesity and viral infections

Experts don't dispute the important role that diet and activity play in maintaining a healthy weight.

23 Oct 2007

Stanford seeks volunteers for flu vaccine study

Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.

22 Oct 2007

Microbix Biosystems granted U.S. patent for its influenza vaccine

Microbix Biosystems Inc. has been granted a patent by the U.S. Patent Office for its technology - VIRUSMAX - which enables vaccine manufacturers to double the amount of influenza vaccine they produce each year.

22 Oct 2007

Educating poor in India helps health and well-being

Simply informing the poor about government-provided health, educational, and social services they are entitled to could empower them to take greater advantage of free or low-cost public services, a study in India suggests.

22 Oct 2007

The truth about your immune system

Vitamins, minerals, and herbal supplements can help complement a healthy diet and lifestyle, but consumers shouldn't count on them to boost their immune response, says the new edition of a Harvard Medical School report, The Truth About Your Immune System: What you need to know.

22 Oct 2007

Human cytomegalovirus may help doctors treat glioblastoma multiforme

A common human virus may prove useful in attacking the deadliest form of brain tumors, according to a study by researchers at Duke's Preston Robert Tisch Brain Tumor Center.

22 Oct 2007

Sanofi Pasteur receives FDA approval of Menactra meningococcal vaccine for children

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), to include children 2 years through 10 years of age.

22 Oct 2007

Fight against HIV needs local scientists

Scientists from developing countries are vitally important in the fight against HIV and they must be given the proper resources to conduct their work, according to a new commentary published today in the journal Nature Immunology.

22 Oct 2007

GenVec receives extra funding for adenovector-based HIV vaccines program

GenVec, Inc. has announced that the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has executed its sixth option period (year seven) under its multi-year collaboration with GenVec to develop and manufacture novel adenovector-based HIV vaccines.

22 Oct 2007

FDA expands approved age range for Menactra, bacterial meningitis vaccine

The U.S. Food and Drug Administration has expanded the approved age range for Menactra, a bacterial meningitis vaccine, to include children ages 2 to 10 years.

19 Oct 2007

Effective vaccine against malaria a very real possibility

The preliminary results of a malaria vaccine trial in African infants show that the vaccine gave a high level of protection and was also safe.

19 Oct 2007

Clinical trial to evaluate glioblastoma multiforme vaccine commences at NYU

A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center.

19 Oct 2007

HPV test beats Pap in detecting cervical cancer

A new study led by McGill University researchers shows that the human papillomavirus (HPV) screening test is far more accurate than the traditional Pap test in detecting cervical cancer.

18 Oct 2007

Researchers take on E. coli 0157 and salmonella

Understanding the ecology of two dangerous foodborne pathogens and devising ways to combat them is a big job.

17 Oct 2007

Discovery of new antibody that helps detect type 1 diabetes

Researchers at the Barbara Davis Center for Childhood Diabetes and University of Colorado at Denver and Health Sciences Center's School of Medicine have discovered a fourth antibody in human blood which will help more accurately predict who is predisposed to type 1 diabetes.

17 Oct 2007